Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretics in hemodialysis patients with residual renal function
NCT04182854Unknown
- Sponsor
- Capital Medical University
- Start
- Oct 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of furosemide and hydrochlorothiazide in Fluid overload and hypertension (HTN), sponsored by Capital Medical University. Primary endpoint: urine volume increasing after diuretic use in maintenance hemodialysis patients with residual renal function at 16 months. Status: unknown.
02
Drugs
furosemidehydrochlorothiazide
03
Conditions
Fluid overloadhypertension (HTN)
Beyond the preview
Go deeper on NCT04182854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04182854.